关注
Paraskevi Kirgou
Paraskevi Kirgou
其他姓名Paraskevi Kyrgou
Biologist, PhD, MSc
在 uth.gr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Target analysis of volatile organic compounds in exhaled breath for lung cancer discrimination from other pulmonary diseases and healthy persons
M Koureas, P Kirgou, G Amoutzias, C Hadjichristodoulou, ...
Metabolites 10 (8), 317, 2020
892020
Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis
T Karampitsakos, S Torrisi, K Antoniou, E Manali, I Korbila, ...
Respiratory research 22 (1), 140, 2021
512021
Repeated antigen-based rapid diagnostic testing for estimating the coronavirus disease 2019 prevalence from the perspective of the workers’ vulnerability before and during the …
OS Kotsiou, I Pantazopoulos, D Papagiannis, EC Fradelos, ...
International Journal of Environmental Research and Public Health 18 (4), 1638, 2021
202021
Pathophysiological aspects of aging in venous thromboembolism: an update
D Akrivou, G Perlepe, P Kirgou, KI Gourgoulianis, F Malli
Medicina 58 (8), 1078, 2022
132022
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation
SA Papiris, D Bouros, K Markopoulou, L Kolilekas, AI Papaioannou, ...
European Respiratory Journal 57 (3), 2021
132021
Mental health and quality of life in pulmonary embolism: a literature review
N Gkena, P Kirgou, KI Gourgoulianis, F Malli
Advances in Respiratory Medicine 91 (2), 174-184, 2023
72023
Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma
OS Kotsiou, I Pantazopoulos, G Mavrovounis, K Marsitopoulos, ...
Journal of Personalized Medicine 12 (11), 1776, 2022
22022
Changes in Smoking Habits in Greece During the Lockdown Measures Due to COVID-19
IC Lampropoulos, P Kirgou, DG Raptis, E Rouka, O Kotsiou, ...
Worldwide Congress on “Genetics, Geriatrics and Neurodegenerative Diseases …, 2022
12022
Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break
P Kirgou, SI Sinis, IE Dimeas, IC Papanikolaou, K Tatsis, A Gogali, ...
Frontiers in Medicine 9, 964722, 2022
12022
Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
T Karampitsakos, O Papaioannou, I Dimeas, P Tsiri, V Sotiropoulou, ...
ERJ Open Research 8 (2), 2022
12022
Cost-IPFfectiveness of antifibrotic treatment: real-life data from a Greek University Hospital
I Dimeas, S Sinis, P Kirgou, L Ioannis, F Malli, K Gourgoulianis, Z Daniil
European Respiratory Journal 56 (suppl 64), 2020
12020
D-ROMs and PAT Tests Reveal a High Level of Oxidative Stress in Patients with Severe Well-Controlled Asthma, and D-ROMs Are Positively Correlated with R20 Values That Indicate …
OS Kotsiou, K Tourlakopoulos, L Kontopoulou, G Mavrovounis, ...
Journal of Personalized Medicine 13 (6), 943, 2023
2023
Investigation of the Level of Burnout in Health Care Professionals in COVID-19 Pandemic Conditions
A Valavani, E Garavela, IV Papathanasiou, K Tsaras, EC Fradelos, ...
Worldwide Congress on “Genetics, Geriatrics and Neurodegenerative Diseases …, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–13